Department of Surgery, University of Maryland School of Medicine, Baltimore, United States; Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, United States.
Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, United States.
Cell Immunol. 2021 Jun;364:104346. doi: 10.1016/j.cellimm.2021.104346. Epub 2021 Mar 26.
Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of immature myeloid cells that expand in inflammatory conditions including transplantation. MDSCs may be capable of controlling rejection. The critical mechanisms underlying MDSC mediated alloregulation remain unexplored. G-CSF potently stimulates MDSC expansion. We hypothesized that G-CSF-induced MDSCs use a novel mechanism to suppress T cell responses. G-CSF promoted expansion of MDSCs and enhanced their suppressive function against T cell proliferation. Gene expression analysis revealed MDSCs expanded with G-CSF upregulated immune-related genes, but downregulated proliferation-related genes when compared to naïve control MDSCs. The KIT oncogene, encoding the c-Kit (CD117) transmembrane tyrosine kinase receptor, was the most significantly increased in MDSCs expanded with G-CSF. c-Kit inhibition with both imatinib and monoclonal blocking antibody reduced expression of ARG-1, iNOS, PD-L1, and SAA3. Further, imatinib also reduced MDSC-mediated T cell suppression in vitro. Modulation of c-Kit activity may represent a therapeutic target for alloregulatory MDSCs.
髓系来源的抑制细胞(MDSC)是一种异质性的未成熟髓系细胞群体,在包括移植在内的炎症条件下扩增。MDSC 可能能够控制排斥反应。MDSC 介导同种调节的关键机制仍未被探索。G-CSF 强烈刺激 MDSC 扩增。我们假设 G-CSF 诱导的 MDSC 利用一种新的机制来抑制 T 细胞反应。G-CSF 促进 MDSC 的扩增,并增强其对 T 细胞增殖的抑制作用。基因表达分析显示,与原始对照 MDSC 相比,用 G-CSF 扩增的 MDSC 上调了免疫相关基因,但下调了增殖相关基因。编码 c-Kit(CD117)跨膜酪氨酸激酶受体的 KIT 癌基因在 G-CSF 扩增的 MDSC 中增加最为显著。用伊马替尼和单克隆阻断抗体抑制 c-Kit,可降低 ARG-1、iNOS、PD-L1 和 SAA3 的表达。此外,伊马替尼还可减少体外 MDSC 介导的 T 细胞抑制。c-Kit 活性的调节可能是同种调节 MDSC 的治疗靶点。